e-learning
resources
Paris 2018
Sunday, 16.09.2018
Primary care management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prediction of future COPD exacerbations - DOSE index or a history of exacerbations?
B. Stallberg (Uppsala, Sweden), M. Högman (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Bröms (Gävle, Sweden), A. Malinovschi (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden)
Source:
International Congress 2018 – Primary care management of COPD
Session:
Primary care management of COPD
Session type:
Thematic Poster
Number:
921
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Stallberg (Uppsala, Sweden), M. Högman (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Bröms (Gävle, Sweden), A. Malinovschi (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden). Prediction of future COPD exacerbations - DOSE index or a history of exacerbations?. 921
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Patterns of cardiopulmonary response to exercise in cardiac diseases
Evaluating the prognosis of cardiac and pulmonary patients
Related content which might interest you:
The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS
Source: International Congress 2014 – COPD exacerbations
Year: 2014
COPD: Influence of patients’ nutritive status on the exacerbations rate
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Mortality and readmissions in patients with severe COPD. Validation of the CODEX index
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?”
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014
COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014
What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Importance of the initial behaviour of patients in avoiding late recovery from COPD exacerbations
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Assessing COPD profiles and outcomes by dyspnoea severity
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Can we personalize COPD treatment by exacerbation frequency and severity? Three years of follow-up
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept